The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.
Amp Health VP on COEs Transforming Workplace Wellness – Q/A
Rich Walsh, VP of Business Development at Amp Health In today’s demanding industrial landscape, the urgency of establishing Industrial Labor Centers of Excellence (COEs) has